EA004718B1 - Способ сокращения или прекращения курения - Google Patents

Способ сокращения или прекращения курения Download PDF

Info

Publication number
EA004718B1
EA004718B1 EA200300217A EA200300217A EA004718B1 EA 004718 B1 EA004718 B1 EA 004718B1 EA 200300217 A EA200300217 A EA 200300217A EA 200300217 A EA200300217 A EA 200300217A EA 004718 B1 EA004718 B1 EA 004718B1
Authority
EA
Eurasian Patent Office
Prior art keywords
nicotine
predetermined period
tobacco
transdermal patch
alternative
Prior art date
Application number
EA200300217A
Other languages
English (en)
Russian (ru)
Other versions
EA200300217A1 (ru
Inventor
Стивен Л. Бертон
Original Assignee
Смитклайн Бичам Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Смитклайн Бичам Корпорейшн filed Critical Смитклайн Бичам Корпорейшн
Publication of EA200300217A1 publication Critical patent/EA200300217A1/ru
Publication of EA004718B1 publication Critical patent/EA004718B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EA200300217A 2000-08-02 2001-08-02 Способ сокращения или прекращения курения EA004718B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22268500P 2000-08-02 2000-08-02
PCT/US2001/024360 WO2002009709A1 (fr) 2000-08-02 2001-08-02 Procede permettant de reduire ou d'eliminer le tabagisme

Publications (2)

Publication Number Publication Date
EA200300217A1 EA200300217A1 (ru) 2003-10-30
EA004718B1 true EA004718B1 (ru) 2004-08-26

Family

ID=22833253

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300217A EA004718B1 (ru) 2000-08-02 2001-08-02 Способ сокращения или прекращения курения

Country Status (15)

Country Link
EP (1) EP1313472A4 (fr)
JP (1) JP2004505053A (fr)
KR (1) KR20030022348A (fr)
CN (1) CN1468101A (fr)
AR (1) AR030092A1 (fr)
AU (2) AU2001284704B2 (fr)
BR (1) BR0112837A (fr)
CA (1) CA2418107A1 (fr)
CZ (1) CZ2003306A3 (fr)
EA (1) EA004718B1 (fr)
HU (1) HUP0300680A3 (fr)
MX (1) MXPA03000994A (fr)
PL (1) PL365609A1 (fr)
WO (1) WO2002009709A1 (fr)
ZA (1) ZA200300820B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660754B1 (en) * 2000-02-15 2003-12-09 Smithkline Beecham Corporation Method for reducing or eliminating smoking
US8042550B2 (en) * 2006-11-02 2011-10-25 Vladimir Nikolaevich Urtsev Smoke-simulating pipe

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055478A (en) * 1986-06-19 1991-10-08 Cooper Thomas M Method for stopping smoking

Also Published As

Publication number Publication date
EP1313472A4 (fr) 2006-07-26
MXPA03000994A (es) 2004-08-02
HUP0300680A2 (hu) 2003-08-28
PL365609A1 (en) 2005-01-10
CA2418107A1 (fr) 2002-02-07
AU8470401A (en) 2002-02-13
AU2001284704B2 (en) 2005-10-13
EA200300217A1 (ru) 2003-10-30
HUP0300680A3 (en) 2012-09-28
WO2002009709A8 (fr) 2003-08-07
AR030092A1 (es) 2003-08-13
BR0112837A (pt) 2003-06-24
JP2004505053A (ja) 2004-02-19
EP1313472A1 (fr) 2003-05-28
WO2002009709A1 (fr) 2002-02-07
CZ2003306A3 (cs) 2003-08-13
ZA200300820B (en) 2004-04-22
KR20030022348A (ko) 2003-03-15
CN1468101A (zh) 2004-01-14

Similar Documents

Publication Publication Date Title
Rose Nicotine and nonnicotine factors in cigarette addiction
US5055478A (en) Method for stopping smoking
Russell Nicotine intake and its regulation
RU2262352C2 (ru) Применение агонистов рецепторов b-типа гамма-аминомасляной кислоты и их фармацевтически приемлемых производных при лечении никотиновой зависимости
US4800204A (en) Method of controlling tobacco use
US6660754B1 (en) Method for reducing or eliminating smoking
US5414005A (en) Methods and articles of manufacture for the treatment of nicotine withdrawal and as an aid in smoking cessation
US6630449B2 (en) Method for reducing the effect of nicotine addiction and dependancy
EA004718B1 (ru) Способ сокращения или прекращения курения
US20040024028A1 (en) Method for reducing or eliminating smoking
AU2001284704A1 (en) Method for reducing or eliminating smoking
AU622614B2 (en) Improvements in or relating to organic compounds
WO1995011678A1 (fr) Utilisation de substituts de nicotine pour le traitement du sevrage a la nicotine
WO1990000896A1 (fr) EMPLOI DE BENZO(g)QUINOLEINES DANS LE TRAITEMENT DE L'ACCOUTUMANCE A LA NICOTINE
SU1537259A1 (ru) Средство, подавл ющее влечение к никотину и табачному дыму
Foulds et al. Treating tobacco dependence
Frenk et al. Nicotine Replacement Therapies
Richmond et al. Controlled Trial of the 24-Hour Transdermal Nicotine Patch in Conjunction With Cognitive-Behavioural Therapy: 6-Months’ Results
EA012460B1 (ru) Лекарство и способ для снижения потребления алкоголя и/или табака
Kipnis et al. Smoking cessation treatment calls for individualized approach
Kaul Smoking cessation
CA2037353A1 (fr) Mode d'auto-administration d'un agoniste des recepteurs dopaminergiques d2
Sullivan et al. State of the Art Reviews: Smoking Cessation.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU